Blood test breakthrough could catch ovarian cancer recurrence early
Diagnosis
Not yet recruiting
This study tests a new blood test (OCS) that looks for tiny particles from cancer cells (exosomes) to see if it can spot ovarian cancer returning after treatment. It is for patients whose standard CA125 test was normal before their first treatment. The goal is to find a better wa…
Sponsor: Beihua Kong • Aim: Diagnosis
Last updated May 26, 2026 11:59 UTC